T. Sakurada et al., ANTINOCICEPTIVE EFFECTS IN THE FORMALIN AND CAPSAICIN TESTS AFTER INTRATHECAL ADMINISTRATION OF SUBSTANCE-P ANALOGS IN MICE, European journal of pharmacology, 242(1), 1993, pp. 47-52
The antinociceptive effect of substance P- and substance P-(6-11) anal
ogues containing D-histidine (D-His) in position 9 was examined in mic
e in the formalin and capsaicin tests. [D-Arg1,D-Trp7,9,Leu11]substanc
e P (spantide) was used as reference drug. Intrathecal injections of t
he [D-His9]substance P and substance P-(6-11) analogues at 4.0 nmol re
sulted in no significant antinociception as measured in the 2.0% forma
lin test, although spantide was antinociceptive in the early and late
phases. The early response induced by 0.0625% formalin was reduced sig
nificantly by the [D-His9]substance P and substance P-(6-11) analogues
at 4.0 nmol, which were less potent than spantide. The antinociceptio
n induced by spantide and a few analogues of substance P and substance
P-(6-11) containing D-His was reversed significantly by pretreatment
with 2 mg/kg naloxone, an opioid antagonist. The nociceptive response
to capsaicin was inhibited significantly by lower doses (2.0 nmol) of
the analogues. The antinociception evoked by the analogues was not rev
ersed by naloxone in the capsaicin test. Co-injection of the [D-His9]s
ubstance P and substance P-(6-11) analogues at 2.0 nmol selectively de
creased substance P-induced licking, biting and scratching without aff
ecting the behavioural responses to NK2 and NK3 receptor agonists. Spa
ntide non-selectively inhibited the behavioural responses produced by
not only substance P, but also neurokinin A, D-septide, neurokinin B a
nd eledoisin. The data show that the capsaicin test may be a better me
thod for evaluating neurokinin antagonists than the formalin test.